Award recordCONTRACT

PHARMACY BUYING ASSOCIATION, INC.

PIID 36C77024P0229· VHA· NATIONAL CMOP OFFICE (36C770)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $646,790 net obligations· UEI CN3LREBPMXJ9· MO

Description

CLOMIPHENE CITRATE 50MG TAB 30 CT

First action · last action
2024-05-01 · 2024-12-30
Transactions
4
First transaction's obligation
$161,698
Base + all options value (sum of deltas)
$646,790
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$646,790$0Base award · 2024-05-01 · this action $161,698 · running total $161,698Modification P00001 · 2024-07-24 · this action $161,698 · running total $323,395Modification P00002 · 2024-10-07 · this action $161,698 · running total $485,093Modification P00003 · 2024-12-30 · this action $161,698 · running total $646,790
  • Base2024-05-01+$161,698= $161,698
  • Mod P000012024-07-24+$161,698= $323,395
  • Mod P000022024-10-07+$161,698= $485,093
  • Mod P000032024-12-30+$161,698= $646,790
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-05-01+$161,698$161,698CLOMIPHENE CITRATE 50MG TAB 30 CT
Mod P00001· EXERCISE AN OPTION2024-07-24+$161,698$323,395CLOMIPHENE CITRATE 50MG TAB 30 CT
Mod P00002· EXERCISE AN OPTION2024-10-07+$161,698$485,093CLOMIPHENE CITRATE 50MG TAB 30 CT
Mod P00003· EXERCISE AN OPTION2024-12-30+$161,698$646,790CLOMIPHENE CITRATE 50MG TAB 30 CT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI CN3LREBPMXJ9)

AwardOffice · PSC / listingNet obligationsFY
36C77026P0117NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$35,862FY2026
36C77026P0094NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$23,379FY2026
36C77026P0090NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$8,028FY2026
36C77026P0071NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$514,928FY2026
36C77026P0065NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$36,432FY2026
36C77026P0036NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$2,180,332FY2026

Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C77026P0118HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$30,935FY2026
36C77026P0129DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$76,656FY2026
36C77026P0127DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$58,395FY2026
36C77026P0086SAGENT PHARMACEUTICALS, INCNATIONAL CMOP OFFICE (36C770)$275,580FY2026
36C77026P0095HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$83,520FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77024P0229_3600_-NONE-_-NONE- · retrieved 2026-09-26.